TABLE 4.
Aortic valve surgery.
Pt | Sex | Age | Euro SCORE II |
Creatinine | Time to CASH, y |
Urgency | Pathology | Operation | Concomitant procedure |
Complications | Mortality | Follow-up, y |
1 | m | 54.4 | 16.5 | 1.4 | 0.1 | Urgent | Regurgitation | Mechanical valve | CABG | Bleeding, RRT, stroke, pneumonia | MOF | 0.1 |
2 | m | 52.9 | 6.7 | 1.2 | 2.0 | Urgent | Endocarditis | Biological valve | − | 7.7 | ||
3 | m | 59.3 | 2.7 | n.a. | 5.3 | Elective | Regurgitation | Mechanical valve | − | 0.5 | ||
4 | m | 62.3 | 15.8 | 4.4 | 7.1 | Urgent | Stenosis | Mechanical valve | Mitral + tricuspid | RRT | − | 0.9 |
5 | m | 61.3 | 2.8 | 1.7 | 9.7 | Elective | Stenosis | TAVR, femoral | − | 3.8 | ||
6 | m | 75.1 | 7.0 | 2.1 | 11.4 | Elective | Stenosis | Biological valve | Bleeding | Bleeding | 0.6 | |
7 | m | 83.2 | 5.1 | 1.0 | 22.9 | Elective | Stenosis | TAVR, apical | − | 2.5 | ||
med | 61.3 (56.9–68.7) |
6.7 (4.0–11.4) |
1.5 (1.3–2.0) |
7.1 (3.7–10.6) |
CABG, coronary artery bypass graft; CASH, cardiac surgery after heart transplantation; ICU, intensive care unit; n.a not available; MOF, multi-organ failure; MV, mitral valve; pt, patient; RRT, renal replacement therapy.